Cargando…
Why are biosimilars much more complex than generics?
Autor principal: | Pagani, Eduardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Israelita de Ensino e Pesquisa Albert Einstein
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388725/ https://www.ncbi.nlm.nih.gov/pubmed/30810585 http://dx.doi.org/10.31744/einstein_journal/2019ED4836 |
Ejemplares similares
-
Much more than cigarette smoking
por: Issa, Jaqueline Scholz, et al.
Publicado: (2014) -
Pharmacovigilance of biosimilars – Why is it different from generics and innovator biologics?
por: Oza, B, et al.
Publicado: (2019) -
Pharmacovigilance of biosimilars - Why is it different from generics and innovator biologics?
por: Gupta, Ranjan
Publicado: (2020) -
Is Supersize More than Just Too Much Food?
por: Birnbaum, Linda S.
Publicado: (2012) -
Bacterial adherence: much more than a bond
por: Di Martino, Patrick
Publicado: (2018)